Related Experiment Video
Updated: Oct 1, 2026

06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Long-term survival after gene therapy for a recurrent glioblastoma
C A Valéry1, D Seilhean, O Boyer
1Department of Neurosurgery, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Neurology
|April 10, 2002
Abstract:
A patient presenting with a recurrent glioblastoma (GBM) survived 3 years after suicide gene therapy and finally died of a disseminated breast cancer with no indication of tumor recurrence on MRI. Postmortem analysis showed no evidence of recurrence of the GBM, neither near the initial tumor localization nor in any other area of the brain. Such an evolution is unusual in the course of this disease and may suggest in this particular case a cure of the GBM.

